CHONGQING HUAPONT SHENGCHEM PHARMACEUTICAL CO LTD
CHONGQING HUAPONT SHENGCHEM PHARMACEUTICAL CO LTD (China) holds 19 active US FDA Type II Drug Master Files, has DMF or CEP filings on record for 18 active ingredients and is linked to 2 FDA-registered manufacturing sites. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “CHONGQING HUAPONT SHENGCHEM PHARMACEUTICAL CO LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/chongqing-huapont-shengchem-pharmaceutical-co-ltd
Overview
CHONGQING HUAPONT SHENGCHEM PHARMACEUTICAL CO LTD is an active pharmaceutical ingredient (API) supplier with 16 active FDA Type II Drug Master Files, covering BENIDIPINE HYDROCHLORIDE; BILASTINE; CALCIPOTRIOL ANHYDROUS; CALCIPOTRIOL MONOHYDRATE; CALCIUM LEVOFOLINATE HYDRATE; CRIZOTINIB.
Core services & business areas
Active ingredients with DMF or CEP filings
Substances for which CHONGQING HUAPONT SHENGCHEM PHARMACEUTICAL CO LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
CHONGQING HUAPONT SHENGCHEM PHARMACEUTICAL CO LTD holds 19 active (19 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- ELACESTRANT DIHYDROCHLORIDEActive2026-08-21
- ELACESTRANT DIHYDROCHLORIDEActive2026-06-29
- NINTEDANIB ESYLATEActive2026-06-23
- ISONIAZIDActive2026-02-24
- RUXOLITINIB PHOSPHATEActive2026-02-12
- BENIDIPINE HYDROCHLORIDEActive2025-12-24
- BILASTINEActive2025-08-11
- UPADACITINIB HEMIHYDRATEActive2025-06-05
- PERFLUOROHEXYLOCTANEActive2025-04-02
- ENZALUTAMIDEActive2025-04-01
- FINERENONEActive2025-03-17
- CALCIUM LEVOFOLINATE HYDRATEActive2025-01-24
- POSACONAZOLEActive2024-12-18
- FULVESTRANTActive2024-11-29
- NINTEDANIB ESILATEActive2024-10-31
- CRIZOTINIBActive2024-05-31
- RUXOLITINIB MESYLATEActive2024-03-29
- CALCIPOTRIOL ANHYDROUSActive2013-08-01
- CALCIPOTRIOL MONOHYDRATEActive2013-07-31
Registered manufacturing sites (2)
Physical sites registered with the US FDA and resolved to CHONGQING HUAPONT SHENGCHEM PHARMACEUTICAL CO LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to CHONGQING HUAPONT SHENGCHEM PHARMACEUTICAL CO LTD in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this CHONGQING HUAPONT SHENGCHEM PHARMACEUTICAL CO LTD?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.